In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis

IMPORTANCE: Experimental and epidemiological studies implicate the cannabinoid 1 receptor (CB1R) in the pathophysiology of psychosis. However, whether CB1R levels are altered in the early stages of psychosis and whether they are linked to cognitive function or symptom severity remain unknown. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgan, Faith, Laurikainen, Heikki, Veronese, Mattia, Marques, Tiago Reis, Haaparanta-Solin, Merja, Solin, Olof, Dahoun, Tarik, Rogdaki, Maria, Salokangas, Raimo KR, Karukivi, Max, Di Forti, Marta, Turkheimer, Federico, Hietala, Jarmo, Howes, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613300/
https://www.ncbi.nlm.nih.gov/pubmed/31268519
http://dx.doi.org/10.1001/jamapsychiatry.2019.1427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613300/
https://www.ncbi.nlm.nih.gov/pubmed/31268519
http://dx.doi.org/10.1001/jamapsychiatry.2019.1427

Ejemplares similares